• Teva Chief Accounting Officer Amir Weiss sold 17,289 ordinary shares on Nov. 9, 2026, reducing direct holdings to 3,537.
• Weiss also exercised stock options to acquire 7,755 ordinary shares at $34.70 per share.
• Sales comprised 662 shares at $43.15, 7,093 at $43.0349 and 9,534 at $43.0289.
• The ownership changes were reported in a Form 4 dated Nov. 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva Pharmaceutical Industries Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-458383), on November 12, 2026, and is solely responsible for the information contained therein.